[1]
N. Bhattacharjee, S. Sarkar, and B. Giri, “Impact of endocrine disrupting chemicals (EDCs) on the predisposition of cancer and polycystic ovary syndrome (PCOS): A Note”, J. Drug Delivery Ther., vol. 12, no. 5, pp. 3–7, Sep. 2022, doi: 10.22270/jddt.v12i5.5582.